These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28341308)

  • 41. Enhanced efficacy of anti-D immunoglobulin for treating ITP is not explained by higher immunoglobulin polymer content.
    Dolman C; Thorpe SJ; Thorpe R
    Biologicals; 2001 Jun; 29(2):75-9. PubMed ID: 11580212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The new generation of liquid intravenous immunoglobulin formulations in patient care: a comparison of intravenous immunoglobulins.
    Stein MR
    Postgrad Med; 2010 Sep; 122(5):176-84. PubMed ID: 20861601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?
    Crow AR; Lazarus AH
    Transfus Med Rev; 2008 Apr; 22(2):103-16. PubMed ID: 18353251
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Subcutaneous IgG in neurologic diseases.
    Berger M
    Immunotherapy; 2014; 6(1):71-83. PubMed ID: 24341886
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
    Siragam V; Brinc D; Crow AR; Song S; Freedman J; Lazarus AH
    J Clin Invest; 2005 Jan; 115(1):155-60. PubMed ID: 15630455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pocketbook: Pharmacoeconomic issues related to intravenous immunoglobulin therapy.
    Mahadevia PJ
    Pharmacotherapy; 2005 Nov; 25(11 Pt 2):94S-100S. PubMed ID: 16229680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravenous immunoglobulin in oncology nursing practice.
    Timmerman PR
    Oncol Nurs Forum; 1993; 20(1):69-75. PubMed ID: 8421651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional integrity of intravenous immunoglobulin following irradiation with a virucidal dose of gamma radiation.
    Tran H; Marlowe K; McKenney K; Petrosian G; Griko Y; Burgess WH; Drohan WN; Imboden MA; Kempf C; Boschetti N; Mann DM
    Biologicals; 2004 Jun; 32(2):94-104. PubMed ID: 15454188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
    Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M
    Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Post-marketing observational study on 5% intravenous immunoglobulin therapy in patients with secondary immunodeficiency and recurrent serious bacterial infections.
    Günther G; Dreger B
    Microbiol Immunol; 2013 Jul; 57(7):527-35. PubMed ID: 23607863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does intravenous immune globulin have a role in HIV-infected patients?
    Yap PL
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):59-67. PubMed ID: 8033437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms of action of intravenous immunoglobulins.
    Baerenwaldt A; Biburger M; Nimmerjahn F
    Expert Rev Clin Immunol; 2010 May; 6(3):425-34. PubMed ID: 20441428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanism of action of IVIG and anti-D in ITP.
    Lazarus AH; Crow AR
    Transfus Apher Sci; 2003 Jun; 28(3):249-55. PubMed ID: 12725951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Different brands of intravenous immunoglobulin for primary immunodeficiencies: how to choose the best option for the patient?
    Abolhassani H; Asgardoon MH; Rezaei N; Hammarstrom L; Aghamohammadi A
    Expert Rev Clin Immunol; 2015; 11(11):1229-43. PubMed ID: 26289377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Use of intravenous immunoglobulin preparations (IVIG) in treatment of primary cell immunodeficiencies].
    Siwińska-Gołebiowska H; Czerwińska-Kartowicz I; Markiewicz K
    Postepy Hig Med Dosw; 2002; 56 Suppl():33-40. PubMed ID: 12661412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
    Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Contamination of IgG preparation for intravenous use with IgA. II. Removal of IgA1 from IgG preparation using affinity chomatography on lectin jacalin columns].
    Dovezenski N; Velicković Z; Tosić Lj; Nikolić G; Popović O; Romić M; Djokić M; Mijusković Z
    Srp Arh Celok Lek; 1994; 122 Suppl 1():51-2. PubMed ID: 18173187
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum IgM, IgG and IgA block by F(ab')-dependent mechanism the binding of natural IgG autoantibodies from therapeutic immunoglobulin preparations to self-antigens.
    Djoumerska IK; Tchorbanov AI; Donkova-Petrini VD; Pashov AD; Vassilev TL
    Eur J Haematol; 2005 Feb; 74(2):101-10. PubMed ID: 15654899
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of intravenous immunoglobulin and high dose anti-D immunoglobulin as initial therapy for childhood immune thrombocytopenic purpura.
    Ozsoylu S
    Br J Haematol; 2011 Mar; 152(6):783-4. PubMed ID: 21275947
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.